Tavros was founded with a mission to discover novel targeted cancer therapies using cutting edge genomics technologies to improve outcomes for cancer patients.
Tavros’ team is comprised of talented scientists and leaders with the scientific, discovery and development expertise to advance potential therapies to improve outcomes for cancer patients.
